Dr. Richard Brian Meagher's lab focuses on tackling invasive fungal diseases that pose serious health risks, particularly in immunocompromised patients. The lab has developed a novel drug delivery system using targeted liposomes that can improve the effectiveness of antifungal treatments, significantly enhancing their ability to combat infections caused by fungi such as Candida albicans and Aspergillus fumigatus. Their research aims to create substantial improvements in antifungal therapies, potentially saving many lives.